NCM Boston
NCM Boston
A
)
Andreas CzechBioNTech, Germany
)
Alex KneubehlBaylor College of Medicine, USA
)
Anne-Sophie LebreCHU Reims, France
)
Ailsa MacCalmanUniversity of Exeter, UK
)
Anastasia McKinlayIndiana University & HHMI, USA
)
Amit MathurSanofi, USA
)
Ana PeresThe University of North Carolina at Chapel Hill, USA
)
Aaron VinyColumbia University Irving Medical Center, USA
)
Akelia Wauchope-OdumboAssociate Director, Technical Applications — Americas, Oxford Nanopore Technologies
B
)
Bronya BoydonMachine Learning Bioinformatician, Oxford Nanopore Technologies
)
Bradley HallAsuragen, USA
)
Bryan LelandBioinformatics Manager, Commercial Applications, Oxford Nanopore Technologies
)
Benjamin C. ReinerUniversity of Pennsylvania, USA
)
Brynja SigurpálsdóttirdeCODE genetics, Iceland
C
)
Cory BernhardsDEVCOM Chemical Biological Center, USA
)
Chris BrownVP Strategic Programmes, Oxford Nanopore Technologies
)
Colette CôtéPathoQuest, USA
)
Christian GallardoSeattle Children's Research Institute, USA
)
Carol GreiderUniversity of California, Santa Cruz, USA
)
Chun-Chieh LinDartmouth Health, USA
)
Chad PollardWasatch BioLabs, USA
)
Charles A. SwoffordMIT Center for Biomedical Innovation, USA
)
Carly TyerApplications Scientist, Oxford Nanopore Technologies
)
Carika WeldonCariGenetics, Bermuda
D
)
Daniel K. FabianLonza, UK
)
Dan FordhamDirector, Strategic Product Management EMEA, Oxford Nanopore Technologies
)
Daniel KimUniversity of California, Santa Cruz, USA
)
Dmitrijs RotsErasmus MC, Netherlands
)
David VanHouteRegeneron Pharmaceuticals, USA
)
David YarmoshATCC, USA
)
)
G
)
Gabriela PozoUniversity of San Francisco de Quito, Ecuador
)
Gordon SangheraCEO, Oxford Nanopore Technologies
)
Gaston VondenhoffLonza, The Netherlands
H
)
Heather CarletonCenters for Disease Control & Prevention, USA
)
Helen GunterThe BASE Facility, The University of Queensland, Australia
J
)
Jessica AndersonSenior Field Applications Scientist, Oxford Nanopore Technologies
)
Justin BeckerDana-Farber Cancer Institute & Massachusetts General Hospital, USA
)
Jade BartoloAssociate Director, Automation, Oxford Nanopore Technologies
)
Jack ColicchioSound Agriculture, USA
)
Julie CollensVP, Commercial Operations AMR, Oxford Nanopore Technologies
)
Jimmy CreithField Applications Scientist, Bioinformatics, Oxford Nanopore Technologies
)
J. (Gus) GustafsonUniversity of Washington, USA
)
Julie HaendigesU.S. Food and Drug Administration, USA
K
)
Karine ChoquetUniversity of Sherbrooke, Canada
)
Keith ConnollyModalis Therapeutics, USA
)
Kamil KhanipovThe University of Texas Medical Branch, USA
)
Katherine LawrenceMachine Learning and Bioinformatics Manager, Oxford Nanopore Technologies
L
)
Lucia DaxingerLeiden University Medical Center, Netherlands
)
Lantana GrubVanderbilt University, USA
)
Lakmal JayasingheSenior VP, R&D Biologics, Oxford Nanopore Technologies
)
Laura KamenetzkyCONICET, Argentina
)
Logan MulroneyEMBL-EBI, UK & IIT, Italy
M
)
Matthew BainbridgeRady Children's Institute for Genomic Medicine, USA
)
Michael DeanNational Cancer Institute, USA
)
Mathilde FilserCurie Institute, France
)
Megan L. NoonanWashington University School of Medicine in St. Louis, USA
)
Matt ParkerDirector, Clinical Bioinformatics Software, Oxford Nanopore Technologies
)
Mile SikicGenome Institute of Singapore, A*STAR, Singapore
)
Mike VellaSenior Director, Machine Learning, Oxford Nanopore Technologies
)
)
P
)
Philipp ReschenederSenior Director, Applications Bioinformatics, Oxford Nanopore Technologies
)
Paula SaffieClinica Santa María, Chile
)
R
)
Ranjith AnandeGenesis, USA
)
Rachel O’NeillUniversity of Connecticut, USA
)
Rachel RubinsteinTechnical Product Manager, Software, Oxford Nanopore Technologies
)
Rosemary Sinclair DokosSenior VP, Product and Programme Management, Oxford Nanopore Technologies
)
Radhakrishna TirumalaiMerck & Co., USA
)
Rhydian WindsorResearch Scientist, Machine Learning, Oxford Nanopore Technologies
S
)
Stacy L. SpringsMIT Center for Biomedical Innovation, USA
)
Stephanie AbernathyVice President, Sales, Americas, Oxford Nanopore Technologies
)
Stephanie ChrysanthouMemorial Sloan Kettering Cancer Center, USA
)
Scott HickeyDirector, Commercial Applications, Oxford Nanopore Technologies
)
Shilpa KobrenHarvard Medical School, USA
)
Serge MonpoehoRegeneron Pharmaceuticals, USA
)
Svetlana MadjunkovaCReATe Fertility Centre, Canada
)
Sean McKenzieAssociate Director, Genomic Applications Bioinformatics, Oxford Nanopore Technologies
)
Samuel ShelburneThe University of Texas MD Anderson Cancer Center, USA
)
Sebastian B. TeitzveryTeitz Consulting, Germany
T
)
Thomas GarciaBaylor College of Medicine, USA
)
Tasos GogakosArena BioWorks & Massachusetts General Hospital, USA
)
Tim WalkerApplied Industrial Support Specialist, Oxford Nanopore Technologies
)
)
)
Oxford Nanopore Technologies
David VanHoute
)
- Job title
- Institution
- Regeneron Pharmaceuticals, USA
- Biography
David has been with Regeneron Pharmaceuticals in QC virology since 2015. As the principal scientist he spearheaded the development of NGS-based assays for adventitious agent GMP testing. Currently, he leads a team of eight researchers continuing to modernize QC virology testing using NGS in the GMP space.